Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
540 studies found for:    "Lupus Erythematosus, Systemic"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Active, not recruiting A Phase 2a, Efficacy and Safety Study of Ustekinumab in Systemic Lupus Erythematosus
Condition: Lupus Erythematosus, Systemic
Interventions: Drug: Ustekinumab IV;   Drug: Placebo Infusion;   Drug: Placebo SC;   Drug: Ustekinumab SC;   Other: Concomitant Medication
2 Terminated Pharmacokinetics Study of Epratuzumab in Systemic Lupus Erythematosus (SLE)
Condition: Lupus Erythematosus, Systemic
Intervention: Drug: epratuzumab
3 Not yet recruiting Effect of Qi Gong Training on Quality of Life in Patients With Systemic Lupus Erythematous (LuQi)
Condition: Lupus Erythematosus, Systemic
Intervention: Other: Qi Gong
4 Unknown  Allogeneic Blood Stem Cell Transplantation for Patients With Life-Threatening Systemic Lupus Erythematosus
Condition: Lupus Erythematosus, Systemic
Intervention: Procedure: Hematopoietic Cell Transplantation
5 Completed Anti-CD20 in Systemic Lupus Erythematosus
Condition: Lupus Erythematosus, Systemic
Intervention: Drug: Rituximab
6 Completed MSC2364447C Phase 1b in Systemic Lupus Erythematosus
Condition: Lupus Erythematosus, Systemic
Interventions: Drug: MSC2364447C;   Drug: Placebo
7 Completed
Has Results
Lymphocyte Depletion and Stem Cell Transplantation to Treat Severe Systemic Lupus Erythematosus
Condition: Lupus Erythematosus, Systemic
Interventions: Drug: fludarabine phosphate;   Drug: cyclophosphamide;   Biological: Rituxan (rituximab);   Biological: filgrastim;   Drug: methylprednisolone;   Other: immunologic technique;   Other: laboratory biomarker analysis;   Procedure: autologous hematopoietic stem cell transplantation;   Drug: Diphenhydramine;   Drug: Mesna
8 Unknown  Role of Altered CD40-Ligand Gene Transcription in Systemic Lupus Erythematosus
Condition: Lupus Erythematosus, Systemic
Intervention:
9 Unknown  Study to Evaluate the Natural History of Osteoporosis in Children and Adolescents With Systemic Lupus Erythematosus
Condition: Lupus Erythematosus, Systemic
Intervention:
10 Completed Study Evaluating The SBI-087 In Subjects With Systemic Lupus Erythematosus
Condition: Lupus Erythematosus, Systemic
Intervention: Drug: SBI-087
11 Completed Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
Condition: Lupus Erythematosus, Systemic
Interventions: Drug: Atacicept 75 milligram (mg);   Drug: Atacicept 150 mg;   Drug: Placebo
12 Completed Safety Study of Two Vaccine Strategies in Patients With Systemic Lupus Erythematosus
Condition: Lupus Erythematosus, Systemic
Interventions: Biological: Prevenar® and Pneumo23®;   Biological: Placebo, Pneumo23®
13 Completed
Has Results
Atacicept Phase 2/3 in Generalized Systemic Lupus Erythematosus (APRIL-SLE)
Condition: Lupus Erythematosus, Systemic
Interventions: Drug: Atacicept 75 mg;   Drug: Atacicept 150 mg;   Other: Placebo Comparator
14 Recruiting TAB08 in Patients With Systemic Lupus Erythematosus (SLE), Not Adequately Controlled With Current Treatment
Condition: Lupus Erythematosus, Systemic
Interventions: Drug: TAB08;   Other: Placebo
15 Completed
Has Results
A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus
Condition: Lupus Erythematosus, Systemic
Interventions: Drug: Rituximab;   Drug: Placebo;   Drug: Prednisone;   Drug: Acetaminophen;   Drug: Diphenhydramine
16 Terminated
Has Results
A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus
Condition: Lupus Erythematosus, Systemic
Interventions: Drug: Rituximab;   Drug: Methylprednisolone;   Drug: Acetaminophen;   Drug: Diphenhydramine
17 Completed
Has Results
Safety and Efficacy Study of LymphoStat-B (Belimumab) in Subjects With Systemic Lupus Erythematosus (SLE)
Condition: Lupus Erythematosus, Systemic
Interventions: Drug: Placebo;   Drug: Belimumab 1 mg/kg;   Drug: Belimumab 4 mg/kg;   Drug: Belimumab 10 mg/kg
18 Not yet recruiting A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-56022473 in Subjects With Systemic Lupus Erythematosus
Condition: Lupus Erythematosus, Systemic
Interventions: Drug: JNJ-56022473;   Drug: Placebo
19 Recruiting A Phase II Study to Evaluate Safety and Efficacy of ALX-0061 in Subjects With Systemic Lupus Erythematosus
Condition: Lupus Erythematosus, Systemic
Interventions: Biological: ALX-0061;   Biological: Placebo
20 Recruiting A Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in Subjects With Active Systemic Lupus Erythematosus (SLE)
Condition: Lupus Erythematosus, Systemic
Interventions: Drug: Repository corticotropin injection;   Drug: Placebo gel

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.